secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2026-08-13T12:15:26+00:00
Accession:  0001213900-26-088719
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Q3 FY2026 revenue up 16% to $2.0M; gross margin 59.9%, net loss $2.0M
------------------------------------------------------------------------------

- Product revenue $2.0M, +16% YoY; product gross margin 59.9% vs 53.9% (record).
- New product orders $2.7M in Q3, +43% YoY; backlog $1.7M; FY2026 orders $11.2M.
- Net loss $2.0M ($0.23 basic, $0.28 diluted) vs $1.5M loss prior year; cash $2.0M.
- Received ISO 13485 certification; StereoCED platform expected by end FY2026 for research/IDE studies.
- Lead investor raised stake from 7.4% to 12.5% post-quarter; raised $1.0M via ATM on July 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026088719/0001213900-26-088719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026088719/ea0301787-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-088719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer